Updated results from a phase III trial of sunitinib versus placebo in patients with progressive, unresectable, well-differentiated pancreatic neuroendocrine tumor (NET).
暂无分享，去创建一个
Y. Bang | E. Raymond | A. Vinik | H. Kennecke | J. Picus | P. Metrakos | P. Niccoli | Jen‐Shi Chen | D. Castellano | J. Valle | J. Raoul | I. Borbath | R. Chao | E. Cutsem | Denis Smith | G. Hazel | D. Lu | D. Hoersch | S. Patyna